DEAR DR. ROACH: I have had osteoporosis for a while and recently had a bone density test that again confirmed that I have it. I am not really interested in taking an oral prescription such as Fosamax, ...
PARSIPPANY, N.J. & TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceuticals Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced today the approval of a ...
Please provide your email address to receive an email when new articles are posted on . The FDA has approved abaloparatide, a parathyroid hormone-related peptide analog, to increase bone mineral ...
Other treatments include hormone replacement therapy (estrogens), selective estrogen receptor modulators, calcitonin, and monoclonal antibodies. Denosumab, which binds to receptor activator of nuclear ...
Lille, France — The American College of Physicians (ACP) has just updated its guidelines for osteoporosis treatment. Bernard Cortet, MD, PhD, chairperson of the Osteoporosis Research and Information ...
Osteoporosis is the most common bone disease in the U.S., leading to increased risk of fractures and a weakening of bone strength and structure. Now, new guidelines on who should be tested could lead ...
Side effects of Forteo range from mild body pain and nausea to more serious ones, such as infections and high calcium levels. Long-term use of Forteo may increase the risk of a type of bone cancer, so ...
Jack has a degree in Medical Genetics from the University of Leicester.View full profile Jack has a degree in Medical Genetics from the University of Leicester. A new oral drug compound may be able to ...
Discusses Osteoporosis Treatment Landscape and Clinical Potential of EB613 Oral Tablet April 20, 2026 11:00 AM ...
DEAR DR. ROACH: I have had osteoporosis for a while and recently had a bone density test that again confirmed that I have it. I am not really interested in taking an oral prescription such as Fosamax, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results